Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 293
Selected: 0
NCT IDTitle
NCT06872333Allo HSCT for High Risk Hemoglobinopathies
NCT00281827Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
NCT01099631IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
NCT01526603High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
NCT00620295Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
NCT01056601Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy
NCT01043640Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
NCT04928950Charcoal in Lung Cancer Patients Undergoing TEMLA
NCT00258362Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
NCT05322408HCW9218 in Select Advanced Solid Tumors
NCT06377540MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
NCT01033552Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs
NCT06213298Effect of Kava on Anxiety and Stress in Cancer Survivors
NCT00855114Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
NCT02989844Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT
NCT04530695Diagnosis and Treatment of Periodontal Disease in Patients With AML
NCT07070726UNTOLD Ovarian Cancer Unmet Needs Survey
NCT00303667Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
NCT02500472Investigation of Kava Effects on NNK Metabolism
NCT00293293Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine
NCT00176891Stem Cell Transplant w/Laronidase for Hurler
NCT05708924MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT00869323Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
NCT00369291CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
NCT05120570PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
NCT00383448HSCT for High Risk Inherited Inborn Errors
NCT02156674Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
NCT05025774Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
NCT03850704Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
NCT00703638Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT03297463Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
NCT03609203Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training
NCT00625729Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
NCT00652899Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT01464359T-Cell Depleted Double UCB for Refractory AML
NCT00381888Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
NCT02948062Early Diagnosis Of Childhood Cerebral ALD
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT07541573GTB-5550 in Advanced Solid Tumors
NCT01215981Influenza Vaccine Post Allogeneic Transplant
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT01677949Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
NCT00265863Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites
NCT03934840CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
NCT05363267NF-1, Nutraceutical Intervention
NCT00630253Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
NCT03687073Trial of Indole-3-Carbinol and Silibinin
NCT02670837Study of Cellutome System for Treatment of Individual Lesions in EB Pts
NCT00356941Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC